Works by Mechoulam, Raphael

Results: 108
    1
    2

    Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 8, p. e2120603, doi. 10.1001/jamanetworkopen.2021.20603
    By:
    • Crippa, José Alexandre S.;
    • Zuardi, Antonio W.;
    • Guimarães, Francisco S.;
    • Campos, Alline Cristina;
    • de Lima Osório, Flávia;
    • Loureiro, Sonia Regina;
    • dos Santos, Rafael G.;
    • Souza, José Diogo S.;
    • Ushirohira, Juliana Mayumi;
    • Pacheco, Julia Cozar;
    • Ferreira, Rafael Rinaldi;
    • Mancini Costa, Karla Cristinne;
    • Scomparin, Davi Silveira;
    • Scarante, Franciele Franco;
    • Pires-Dos-Santos, Isabela;
    • Mechoulam, Raphael;
    • Kapczinski, Flávio;
    • Fonseca, Benedito A. L.;
    • Esposito, Danillo L. A.;
    • Pereira-Lima, Karina
    Publication type:
    Article
    3
    4

    Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.

    Published in:
    2001
    By:
    • Bisogno, Tiziana;
    • Hanuš, Lumír;
    • De Petrocellis, Luciano;
    • Tchilibon, Susanna;
    • Ponde, Datta E;
    • Brandi, Ines;
    • Moriello, Aniello Schiano;
    • Davis, John B;
    • Mechoulam, Raphael;
    • Di Marzo, Vincenzo;
    • Bisogno, T;
    • Hanus, L;
    • De Petrocellis, L;
    • Tchilibon, S;
    • Ponde, D E;
    • Brandi, I;
    • Moriello, A S;
    • Davis, J B;
    • Mechoulam, R;
    • Di Marzo, V
    Publication type:
    journal article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    PADMA-28, a traditional Tibetan herbal preparation inhibits the respiratory burst in human neutrophils, the killing of epithelial cells by mixtures of oxidants and pro-inflammatory agonists and peroxidation of lipids.

    Published in:
    Inflammopharmacology, 1999, v. 7, n. 1, p. 47, doi. 10.1007/s10787-999-0025-9
    By:
    • Ginsburg, Isaac;
    • Sadovnik, Milu;
    • Sallon, Sarah;
    • Milo-Goldzweig, Ilana;
    • Mechoulam, Raphael;
    • Breuer, Aviva;
    • Gibbs, Douglas;
    • Varani, James;
    • Roberts, Stanley;
    • Cleator, Edward;
    • Singh, Neirmal
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Towards a better cannabis drug.

    Published in:
    British Journal of Pharmacology, 2013, v. 170, n. 7, p. 1363, doi. 10.1111/bph.12400
    By:
    • Mechoulam, Raphael;
    • Parker, Linda
    Publication type:
    Article
    29

    A new cannabinoid CB<sub>2</sub> receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.

    Published in:
    British Journal of Pharmacology, 2012, v. 165, n. 8, p. 2462, doi. 10.1111/j.1476-5381.2011.01381.x
    By:
    • Horváth, Bėla;
    • Magid, Lital;
    • Mukhopadhyay, Partha;
    • Bátkai, Sándor;
    • Rajesh, Mohanraj;
    • Park, Ogyi;
    • Tanchian, Galin;
    • Gao, Rachel Y;
    • Goodfellow, Catherine E;
    • Glass, Michelle;
    • Mechoulam, Raphael;
    • Pacher, Pál
    Publication type:
    Article
    30
    31
    32

    Prospects for cannabinoid therapies in basal ganglia disorders.

    Published in:
    2011
    By:
    • Fernández-Ruiz, Javier;
    • Moreno-Martet, Miguel;
    • Rodríguez-Cueto, Carmen;
    • Palomo-Garo, Cristina;
    • Gómez-Cañas, María;
    • Valdeolivas, Sara;
    • Guaza, Carmen;
    • Romero, Julián;
    • Guzmán, Manuel;
    • Mechoulam, Raphael;
    • Ramos, José A;
    • Fernández-Ruiz, Javier;
    • Rodríguez-Cueto, Carmen;
    • Gómez-Cañas, María;
    • Romero, Julián;
    • Guzmán, Manuel;
    • Ramos, José A
    Publication type:
    journal article
    33
    34
    35
    36

    Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in N -Oleoylglycine and N -Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These Mediators.

    Published in:
    Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.706703
    By:
    • Ayoub, Samantha M.;
    • Piscitelli, Fabiana;
    • Silvestri, Cristoforo;
    • Limebeer, Cheryl L.;
    • Rock, Erin M.;
    • Smoum, Reem;
    • Farag, Mathew;
    • de Almeida, Hannah;
    • Sullivan, Megan T.;
    • Lacroix, Sébastien;
    • Boubertakh, Besma;
    • Nallabelli, Nayudu;
    • Lichtman, Aron H;
    • Leri, Francesco;
    • Mechoulam, Raphael;
    • Di Marzo, Vincenzo;
    • Parker, Linda A.
    Publication type:
    Article
    37
    38

    Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats.

    Published in:
    Psychopharmacology, 2020, v. 237, n. 9, p. 2753, doi. 10.1007/s00213-020-05570-4
    By:
    • Ayoub, Samantha M.;
    • Smoum, Reem;
    • Farag, Mathew;
    • Atwal, Harkirat;
    • Collins, Stephen A.;
    • Rock, Erin M.;
    • Limebeer, Cheryl L.;
    • Piscitelli, Fabiana;
    • Iannotti, Fabio Arturo;
    • Lichtman, Aron H.;
    • Leri, Francesco;
    • Di Marzo, Vincenzo;
    • Mechoulam, Raphael;
    • Parker, Linda A.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    Cannabis - the Israeli perspective.

    Published in:
    Journal of Basic & Clinical Physiology & Pharmacology, 2016, v. 27, n. 3, p. 181, doi. 10.1515/jbcpp-2015-0091
    By:
    • Mechoulam, Raphael
    Publication type:
    Article
    45
    46
    47
    48
    49
    50